Whereas FAK elevated levels and gene amplification have been well-demonstrated in breast cancer [26-28] and in the triple negative subtypes [29] respectively, only recently the association between tumor endothelial-FAK expression and breast cancer subtypes has been explored [30]. This evidence concerns the gene PTK2 and breast carcinoma.